Managing smoking cessation mental illness remains a significant challenge for healthcare providers globally. The KISMET cluster-randomized trial, recently conducted in the Netherlands, evaluated a specialized intervention for individuals with severe mental illness (SMI). This one-year study aimed to bridge the gap between psychiatric care and physical health by offering a structured quitting program within outpatient mental healthcare teams. Consequently, researchers focused on long-term abstinence rather than short-term success alone.

Effectiveness of the KISMET Intervention

The study highlights that specialized programs can effectively support smoking cessation mental illness goals. Eleven teams delivered the KISMET intervention, while ten provided treatment as usual. Specifically, the intervention combined cognitive-behavioral therapy and peer support with optional pharmacological treatments. The results showed significantly higher cessation rates in the intervention group at three months and twelve months. However, the differences were not statistically significant at the six-month mark. Therefore, the timing of support may be crucial for maintaining motivation.

Secondary Outcomes and Patient Safety

Clinicians often worry about the psychiatric stability of patients during quit attempts. Fortunately, this trial found no significant physical or psychopathological complications associated with the intervention. Secondary outcomes, including depression, anxiety, and psychotic symptom severity, remained stable across both groups. Additionally, physical parameters like blood pressure and body mass index showed no detrimental changes. Nevertheless, the high dropout rate of 58% in the intervention group suggests that maintaining long-term engagement is difficult. This high attrition rate indicates that future programs might require more personalized approaches.

Conclusion and Clinical Implications

The KISMET intervention demonstrates significant potential for integrating lifestyle changes into standard psychiatric care. While the quit rates are promising, the high attrition highlights a need for more resilient support systems. Moreover, the integration of peer support and pharmacotherapy appears to be a safe and effective pathway for this vulnerable population. Providers should consider these findings when designing tobacco cessation protocols for patients with severe mental disorders.

Frequently Asked Questions

What are the core components of the KISMET intervention?

The intervention includes cognitive-behavioral therapy, peer support groups led by experts-by-experience, and optional pharmacological treatment, such as nicotine replacement therapy or other cessation medications.

Is smoking cessation safe for patients with psychotic symptoms?

Yes, the KISMET trial and broader literature indicate that smoking cessation does not worsen psychiatric symptoms when managed correctly by clinical teams within a mental health setting.

Why were the dropout rates high in this study?

Severe mental illness often involves cognitive and motivational challenges. Consequently, participants may find long-term, intensive behavioral programs difficult to complete without extensive individual tailoring and consistent encouragement.

Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Refer to the latest local and national guidelines for clinical practice.

References

1. K眉莽眉kaksu M et al. Effectiveness of a one-year smoking cessation intervention for people with severe mental illness: results of the KISMET cluster-randomized controlled trial. Psychol Med. 2026 May 15. doi: 10.1017/S0033291726104516. PMID: 42138038.

2. Ministry of Health and Family Welfare, Government of India. Tobacco Dependence Treatment Guidelines.

3. World Health Organization. WHO treatment recommendations for tobacco cessation in people with severe mental illness.